Drug Shortage Report for SANDOZ IRBESARTAN

Last updated on 2020-05-11 History
Report ID 80205
Drug Identification Number 02328488
Brand name SANDOZ IRBESARTAN
Common or Proper name IRBESARTAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-05
Estimated end date 2020-06-12
Actual end date
Shortage status Actual shortage
Updated date 2020-05-11
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2020-05-11 French Compare
v27 2020-05-11 English Compare
v26 2020-05-04 French Compare
v25 2020-05-04 English Compare
v24 2020-04-06 French Compare
v23 2020-04-06 English Compare
v22 2020-03-30 French Compare
v21 2020-03-30 English Compare
v20 2020-02-15 French Compare
v19 2020-02-15 English Compare
v18 2020-01-08 French Compare
v17 2020-01-08 English Compare
v16 2019-12-10 French Compare
v15 2019-12-10 English Compare
v14 2019-11-18 French Compare
v13 2019-11-18 English Compare
v12 2019-10-15 French Compare
v11 2019-10-15 English Compare
v10 2019-06-12 French Compare
v9 2019-06-12 English Compare

Showing 1 to 20 of 28